Status:
WITHDRAWN
Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease
Lead Sponsor:
US Department of Veterans Affairs
Conditions:
Parkinson's Disease
Eligibility:
All Genders
50-80 years
Phase:
NA
Brief Summary
This is an open-label cross-over randomized control study comparing the effect of modafinil and methylphenidate in patients with Parkinson's disease with excessive daytime sleepiness.
Detailed Description
Sleep disorders are common in Parkinson's disease (PD) and a significant cause of impairment of function in already disabled individuals. Almost all patients with PD report disturbed sleep, including ...
Eligibility Criteria
Inclusion
- Veteran at study site
Exclusion
- Patients unable to give consent
- Diagnosis of EDS prior to diagnosis of PD
- Brain injury due to trauma, CVA, tumor or anoxia
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00393562
Start Date
March 1 2006
End Date
October 1 2007
Last Update
June 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Philadelphia, OPC
Philadelphia, Pennsylvania, United States, 19106